We are live on ! Find out more
NUS icon

Nu Skin

198 hedge funds and large institutions have $548M invested in Nu Skin in 2024 Q1 according to their latest regulatory filings, with 30 funds opening new positions, 72 increasing their positions, 65 reducing their positions, and 44 closing their positions.

New
Increased
Maintained
Reduced
Closed

11% more repeat investments, than reductions

Existing positions increased: 72 | Existing positions reduced: 65

4.77% less ownership

Funds ownership: 84.8%80.03% (-4.8%)

7% less funds holding

Funds holding: 212198 (-14)

32% less first-time investments, than exits

New positions opened: 30 | Existing positions closed: 44

33% less capital invested

Capital invested by funds: $814M → $548M (-$266M)

40% less call options, than puts

Call options by funds: $1.63M | Put options by funds: $2.72M

Holders
198
Holders Change
-14
Holders Change %
-6.6%
% of All Funds
2.85%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
30
Increased
72
Reduced
65
Closed
44
Calls
$1.63M
Puts
$2.72M
Net Calls
-$1.08M
Net Calls Change
+$1.14M
Name Holding Trade Value Shares
Change
Change in
Stake
BlackRock
1
BlackRock
New York
$115M -$2.54M -162,718 -2%
Vanguard Group
2
Vanguard Group
Pennsylvania
$89.8M +$4.28M +274,309 +4%
State Street
3
State Street
Massachusetts
$28.2M -$13M -832,200 -29%
Renaissance Technologies
4
Renaissance Technologies
New York
$24.9M -$2.03M -129,800 -7%
Charles Schwab
5
Charles Schwab
California
$19.2M +$3.62M +231,508 +20%
Morgan Stanley
6
Morgan Stanley
New York
$16.2M -$12.1M -776,156 -40%
Geode Capital Management
7
Geode Capital Management
Massachusetts
$15M +$277K +17,729 +2%
Dimensional Fund Advisors
8
Dimensional Fund Advisors
Texas
$14.8M -$5.03M -321,971 -23%
D.E. Shaw & Co
9
D.E. Shaw & Co
New York
$13.6M +$8.52M +545,531 +125%
Bank of New York Mellon
10
Bank of New York Mellon
New York
$11.9M +$322K +20,613 +2%
ACB
11
Aristotle Capital Boston
Massachusetts
$11.2M +$193K +12,342 +2%
Federated Hermes
12
Federated Hermes
Pennsylvania
$8.64M +$4.59M +294,008 +89%
ProShare Advisors
13
ProShare Advisors
Maryland
$8.27M +$2.5M +159,831 +37%
Norges Bank
14
Norges Bank
Norway
$7.61M +$1.41M +90,589 +20%
Northern Trust
15
Northern Trust
Illinois
$7.37M -$297K -18,994 -3%
Invesco
16
Invesco
Georgia
$7.07M -$36.6M -2,345,787 -82%
American Century Companies
17
American Century Companies
Missouri
$6.46M +$1.64M +105,058 +29%
Two Sigma Advisers
18
Two Sigma Advisers
New York
$6.2M +$22.2K +1,422 +0.3%
Hotchkis & Wiley Capital Management
19
Hotchkis & Wiley Capital Management
California
$6.06M +$2.15M +137,580 +46%
Citadel Advisors
20
Citadel Advisors
Florida
$5.78M -$1.75M -112,188 -21%
Marshall Wace
21
Marshall Wace
United Kingdom
$5.02M +$3.44M +220,560 +155%
Allianz Asset Management
22
Allianz Asset Management
Germany
$4.83M +$1.93M +123,302 +55%
Jacobs Levy Equity Management
23
Jacobs Levy Equity Management
New Jersey
$3.92M +$2.83M +181,528 +178%
Millennium Management
24
Millennium Management
New York
$3.69M -$158K -10,143 -4%
Principal Financial Group
25
Principal Financial Group
Iowa
$3.55M -$15.6K -998 -0.4%

NUS Hedge Fund Activity: Q1 2024 in Review

198 of the 6,942 institutional investors tracked by Wall St. Rank reported a position in Nu Skin (NUS) for Q1 2024, worth a combined $548M — down 33% from $814M a quarter earlier.

Sellers outnumbered buyers: 44 funds closed out of NUS and 30 opened new positions — a net loss of 14 holders — while 65 trimmed existing stakes and 72 added.

The largest buyer was D.E. Shaw & Co, adding an estimated $8.52M. The largest seller was Invesco, cutting an estimated $36.6M.

  • 198 institutional investors held Nu Skin (NUS) as of Q1 2024, down from 212 in Q4 2023.
  • Funds reported $548M of Nu Skin stock for Q1 2024, down 33% quarter-over-quarter.
  • 30 funds opened new Nu Skin positions in Q1 2024 and 44 closed out, a net change of -14 holders.
  • The largest Nu Skin buyer in Q1 2024 was D.E. Shaw & Co, an estimated $8.52M added.
  • The largest Nu Skin seller in Q1 2024 was Invesco, an estimated $36.6M sold.

Based on aggregated 13F filings for Q1 2024.